U.S. FDA

We’re delivering for cancer patients who have been waiting for game-changing therapies.

Another busy week at FDA!

Are you ready to shape the future of public health at the highest levels? The FDA is seeking an exceptional executive leader to serve as the Center Director for CBER—a role at the forefront of regulating life-saving biological products, vaccines, and emerging therapies. This is an opportunity to protect and advance public health on a national scale. You'll work on cutting-edge science, shape critical regulatory policy, and lead a team dedicated to ensuring the safety and effectiveness of biological products that save lives. Apply by April 3, 2026. #FDAJobs usajobs.gov/job/862056100?…

As you enjoy more real foods under the new Dietary Guidelines for Americans, don’t forget to practice food safety. Follow these steps when cleaning fruits 🍊 🍎 and vegetables 🥕 🥦 to reduce dirt and bacteria. fda.gov/consumers/cons… #NationalNutritionMonth #EatRealFoodSafely

If a drug is already widely used in humans abroad, the FDA shouldn’t require routine testing in animals.

The FDA seeks public input on the Commissioner's National Priority Voucher program—an ultra-fast review pathway for drugs of strategic national importance. The agency has awarded vouchers for 18 products and granted four approvals, including two oncology drug approvals that were delivered in less than 60 days. Join us on June 12 for a public hearing. fda.gov/news-events/pr…

Today: another action to stop unnecessary animal testing. We can do better.

Another impressive result for the national priority voucher program. 54 days for a full FDA review! 🇺🇸

FDA approves Wegovy HD, a higher-dose Wegovy (7.2 mg semaglutide), in just 54 days—marking the 4th success under @DrMakaryFDA's National Priority Voucher pilot program. Learn more about how FDA is accelerating access to innovative treatments: fda.gov/news-events/pr…

FDA announces an April 23 public meeting and comment period - "Increasing Access to Nonprescription Drugs". Join the conversation on expanding safe, effective nonprescription drug access. Discussion on industry challenges, scientific opportunities & collaboration. Learn more: fda.gov/news-events/fd…

Some FDA decisions are taking WEEKS. Thank you to the dedicated FDA scientists who are making this unprecedented efficiency possible.

🎉🥗 This #NationalNutritionMonth, we’re celebrating 120 years of the FDA helping protect and promote public health. 🎂🎊 From food safety to nutrition information, FDA supports informed choices so families can feel confident about what’s on their plates today and every day. #FDA120 #EatInformed #EatRealFoodSafely

Fewer animals. Better data. Faster cures. Today’s draft guidance on New Approach Methodologies (NAMs) accelerates the shift to human-centric science—advancing ethical, more predictive, and faster drug development. fda.gov/news-events/pr…

I never imagined 5,000 gathering to talk about medical quality. As @DrOzCMS says, the most expensive part of health care is poor quality care.

Kids don’t need to tip-toe around healthy fats in food.

We must go big when it comes to biotech regulatory reform—unapologetically America First. Thank you @DrOzCMS for hosting @NIHDirector_Jay & I in Baltimore.

Learn how @US_FDA’s Office of Coordinated Outbreak Response, Evaluation & Emergency Preparedness works to find, stop, and help prevent foodborne illness outbreaks in foods like carrots, cheese, chocolate and many others in their annual report. fda.gov/food/hfp-const…

FDA is setting new records in how rapid we are approving cancer drugs—some are so powerful, they have the potential to bring patients out of hospice.

Pro tip: FDA-approved spirulina extract can be a great natural alternative to artificial petroleum-based green dyes.

Colorectal cancer impacts women too. Screening may save your life. @US_FDA provides information about the different screening options available to you. Learn more: fda.gov/consumers/cons…